The TGFBR1*6A allelic frequency also ranged from 6.1 to 12.8% among breast cancer patients from northern and southwestern Europe, including samples from the UK36, Spain32, Sweden37, Finland38, Poland38,39, and Ireland40 (Table 1). Here, TGFBR1 is linked to breast carcinoma.